1. The purpose of this Act is to establish specific rules applicable to the recovery of opioid-related health care costs attributable to a wrong committed by one or more opioid product manufacturers or wholesalers, or one or more consultants to them, in particular to allow the recovery of those costs regardless of when the wrong was committed.
It also seeks to make certain of those rules applicable to the recovery of damages for an injury attributable to a wrong committed by one or more of those manufacturers, wholesalers or consultants.
2023, c. 252023, c. 25, s. 1.